Cargando…

Serum HBV RNA is a Potential Predictor of Hepatitis B Surface Antigen Reversion

Detalles Bibliográficos
Autores principales:	Wang, Jie, Chen, Xiangmei, Wu, Yali, Cao, Zhenhuan, Wang, Leijie, Huang, Hongxin, Chen, Xinyue, Lu, Fengmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167077/ https://www.ncbi.nlm.nih.gov/pubmed/30288471 http://dx.doi.org/10.1002/hep4.1249

Ejemplares similares

Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis
por: Wang, Leijie, et al.
Publicado: (2020)

Serum anti-hepatitis B surface antigen in hemodialysis patients
por: Rafieian-Kopaei, Mahmoud, et al.
Publicado: (2012)

Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries
por: Qian, Xiangjun, et al.
Publicado: (2019)

Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen Carriers
por: Li, Hong, et al.
Publicado: (2022)

Diagnostic Value of Serum Golgi Protein 73 for Liver Inflammation in Patients with Autoimmune Hepatitis and Primary Biliary Cholangitis
por: Yao, Mingjie, et al.
Publicado: (2022)

Severe acute hepatitis in children with unknown aetiology, etiology analysis and the next action
por: Gao, Yuan, et al.
Publicado: (2022)

A standardized assay for the quantitative detection of serum HBV RNA in chronic hepatitis B patients
por: Yu, Guangxin, et al.
Publicado: (2022)

Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
por: Lin, Xiao, et al.
Publicado: (2022)

Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication In Vivo
por: Zhu, Wenbo, et al.
Publicado: (2012)

Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis
por: Song, Aixin, et al.
Publicado: (2021)

Cost-effectiveness of combination antiviral treatment with extended duration for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B in China
por: Li, Runqin, et al.
Publicado: (2021)

Hepatitis B Surface Antigen Concentrations in Patients with HIV/HBV Co-Infection
por: Jaroszewicz, Jerzy, et al.
Publicado: (2012)

Correlation Between Hepatitis B Surface Antigen Titers and HBV DNA Levels
por: Alghamdi, Amal, et al.
Publicado: (2013)

Clinical Features and T Cell Immune Characteristics of Postpartum Hepatitis Flare in Pregnant Women With HBeAg-Positive Chronic HBV Infection
por: Song, Aixin, et al.
Publicado: (2022)

Characterization of HBV surface antigen isoforms in the natural history and treatment of HBV infection
por: Rodgers, Mary A., et al.
Publicado: (2023)

Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen
por: Kuhns, Mary C., et al.
Publicado: (2021)

Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population
por: Zeng, Zhenzhen, et al.
Publicado: (2015)

ELISA for Quantitative Determination of Hepatitis B Virus Surface Antigen
por: Kim, Se-Ho
Publicado: (2017)

High Serum Levels of TGF-β in Iranians With Chronic HBV Infection
por: Khorramdelazad, Hossein, et al.
Publicado: (2012)

The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry
por: Sun, Yeping, et al.
Publicado: (2018)

Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production
por: Phillips, Sandra, et al.
Publicado: (2015)

Pacbio Sequencing of PLC/PRF/5 Cell Line and Clearance of HBV Integration Through CRISPR/Cas-9 System
por: Chen, Chia-Chen, et al.
Publicado: (2021)

KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians
por: Yindom, Louis-Marie, et al.
Publicado: (2017)

Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay
por: Park, Joonhong, et al.
Publicado: (2019)

Hepatitis B virus reactivation after treatment for hepatitis C in hemodialysis patients with HBV/HCV coinfection
por: Wahle, Raul Carlos, et al.
Publicado: (2015)

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B
por: Liem, Kin Seng, et al.
Publicado: (2019)

Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients
por: Liao, Hao, et al.
Publicado: (2022)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

Serum HBV Surface Antigen Positivity is Associated With Low Prevalence of Metabolic Syndrome in Korean Adult Men
por: Choi, Ja Sung, et al.
Publicado: (2015)

Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis
por: Li, Yuanyuan, et al.
Publicado: (2017)

Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
por: Mak, Lung-Yi, et al.
Publicado: (2020)

Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues
por: Wang, Yang, et al.
Publicado: (2022)

Freeze-Drying of Plant Tissue Containing HBV Surface Antigen for the Oral Vaccine against Hepatitis B
por: Czyż, Marcin, et al.
Publicado: (2014)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
por: Lim, Young-Suk
Publicado: (2023)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

How Can We Make Decision for Patients With Chronic Hepatitis B According to Hepatitis B Virus (HBV) DNA Level?
por: Keshvari, Maryam, et al.
Publicado: (2014)

Study on the Retreatment, Outcome, and Potential Predictors of Recurrence in Patients With Recurrence of Hepatitis B After Functional Cure
por: Lin, Xiao, et al.
Publicado: (2022)

RNA binding protein TIAR modulates HBV replication by tipping the balance of pgRNA translation
por: Zhang, Ting, et al.
Publicado: (2023)

Development and evaluation of a semi-nested PCR technique for amplification and determination of different surface gene variation patterns in patients with chronic HBV infection: development of an amplification method for HBV S gene
por: Mokhtari, Fedra, et al.
Publicado: (2023)

Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?
por: Brancaccio, Giuseppina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_krv2d3nrbr1ft0ca7uank0thr7